AI Generated Image
RFK Jr. wants to make it easier to get peptides. FDA scientists disagree.
NBC News • • business
Key Points:
- Health Secretary Robert F. Kennedy Jr. supports deregulating several peptides, but FDA scientists report insufficient evidence to endorse their use, citing safety and efficacy concerns.
- The FDA advisory committee will review seven peptides in July to decide if compounding pharmacies can produce them, despite many lacking human studies and existing FDA-approved treatments for related conditions.
- Peptides are widely available online in an unregulated "gray market," often labeled "For research use only," raising safety issues such as contamination and mislabeling.
- Some new FDA advisory committee members have ties to wellness centers promoting peptides, raising potential conflicts of interest as the panel evaluates these substances.
- Experts caution against approving peptides without robust human data, highlighting a possible double standard compared to the rigorous testing required for vaccines and other therapies.
